| 000 | 01433 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250511223354.0 | ||
| 264 | 0 | _c19901231 | |
| 008 | 199012s 0 0 eng d | ||
| 022 | _a0006-4971 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aClark, M R | |
| 245 | 0 | 0 |
_aPermeability characteristics of deoxygenated sickle cells. _h[electronic resource] |
| 260 |
_bBlood _cNov 1990 |
||
| 300 |
_a2139-45 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _a4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid |
| 650 | 0 | 4 |
_a4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAnemia, Sickle Cell _xmetabolism |
| 650 | 0 | 4 |
_aArabinose _xpharmacokinetics |
| 650 | 0 | 4 |
_aCell Membrane Permeability _xdrug effects |
| 650 | 0 | 4 |
_aChlorides _xpharmacokinetics |
| 650 | 0 | 4 |
_aCytochalasin B _xpharmacology |
| 650 | 0 | 4 |
_aDiamide _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aErythritol _xpharmacokinetics |
| 650 | 0 | 4 |
_aErythrocyte Membrane _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMannitol _xpharmacokinetics |
| 650 | 0 | 4 |
_aOuabain _xpharmacology |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 650 | 0 | 4 |
_aPotassium _xpharmacokinetics |
| 650 | 0 | 4 |
_aSodium _xpharmacokinetics |
| 650 | 0 | 4 |
_aSulfates _xpharmacokinetics |
| 700 | 1 | _aRossi, M E | |
| 773 | 0 |
_tBlood _gvol. 76 _gno. 10 _gp. 2139-45 |
|
| 999 |
_c2129069 _d2129069 |
||